Article
AbbVie Makes Another Big Pharma Acquisition. How It's Putting Its Cash to Work.
Rating:
0.0
Views:
44
Likes:
1
Library:
1
AbbVie said late Wednesday it will buy Cerevel Therapeutics for $45 a share, or about $8.7 billion, in an all-cash deal.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value